Q4 2024 Alleima AB Earnings Call Transcript
Key Points
- Alleima AB (STU:M46) achieved revenue growth and stable earnings despite a challenging economic environment in 2024.
- The company saw strong performance in the Oil and Gas, Nuclear, and Medical segments, contributing positively to revenue.
- Alleima AB (STU:M46) maintained a solid order backlog, particularly in key segments like Nuclear and Medical, ensuring future revenue streams.
- The company is actively investing in growth initiatives, including reopening facilities and expanding capacity in strategic regions like Japan and Malaysia.
- A proposed dividend increase of 37% reflects Alleima AB (STU:M46)'s commitment to shareholder value.
- Organic order intake growth declined by 6% over a rolling 12-month period, primarily due to a weaker Oil and Gas segment.
- The Industrial segment remains less profitable, and the company is not prioritizing growth in this area.
- Free operating cash flow decreased compared to the previous year, impacted by higher capital expenditures.
- The Chemical and Petrochemical segment faced weakness, particularly in Europe, affecting overall performance.
- The company is experiencing challenges in the Renewable Energy segment, with some slowdown in the green transition.
Hi, everyone, and welcome to the presentation of the fourth-quarter and full year 2024 report for Alleima. My name is Emelie Alm and I am Head of Investor Relations. I'm joined by Goran Bjorkman, President and CEO, and Olof Bengtsson, CFO. Goran and Olof will take you through our results and then we will have a Q&A session.
You can ask questions through the conference call and you can also write them in the field beside the webcast. And you can also download the presentation from alleima.com. And as always, safety is a top priority for us. So I trust that you are safe now and that you know the safety routines of where you are located.
So with that, I would like to hand over to you, Goran.
Thank you, Emelie. And hi, everyone, and thank you for listening.
Starting with the summing up the year, which was generally a more challenging year than 2023. At the same time, I think we show strength and deliver revenue
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
